Effect of Carrilizumab Combined with Irinotecan on Gastric Cancer and Serum BARD1 and STAT1

ZHANG Hui; HUANG Wen; PAN Ying

doi:10.3969/j.issn.2095-3097.2023.03.004

Home>Articles>Effect of Carrilizumab Combined with Irinotecan on Gastric Cancer and Serum BARD1 and STAT1

DOI: 10.3969/j.issn.2095-3097.2023.03.004

Effect of Carrilizumab Combined with Irinotecan on Gastric Cancer and Serum BARD1 and STAT1

ZHANG Hui

HUANG Wen

PAN Ying

Keywords：Gastric neoplasmsCamrelizumabIrinotecanCarbohydrate antigen 199Carcinoembryonic antigenCD4+Serum breast cancer gene 1-related ring finger proteinTranscriptional activation protein 1

Publication Date：2023-06-20

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 147-151 )

Translational Medicine Journal

ISTIC

ISSN：2095-3097

Year, Vol.(Issue)：2023,12(3)